Actively Recruiting
Distal Perfusion Timing, Early or Conservative, to Prevent Limb Ischemia During Peripheral VA-ECMO
Led by Min-Seok Kim · Updated on 2023-06-15
400
Participants Needed
1
Research Sites
200 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Peripheral VA-ECMO is widely used in refractory cardiogenic shock patients as a salvage therapy. In most cases, the femoral artery and vein are used for the vascular approach. Large cannulas are usually used for proper oxygenation, which may cause peripheral limb ischemia. Distal perfusion catheterization (DPC) at the ipsilateral arterial cannula site is recommended to prevent distal limb ischemia. However, there is no consensus on the proper timing of DPC and additional invasive procedures may cause complications during VA-ECMO support. In this analysis, the investigators compare the clinical outcomes of distal limb ischemia complications between the conventional DPC group (DPC at the time of limb ischemia sign) and the preemptive DPC group (DPC at the time of VA-ECMO application).
CONDITIONS
Official Title
Distal Perfusion Timing, Early or Conservative, to Prevent Limb Ischemia During Peripheral VA-ECMO
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age 19 years or older
- Refractory cardiogenic shock with peripheral VA-ECMO
- Able to provide informed consent
You will not qualify if you...
- Unable or unwilling to provide informed consent
- Currently pregnant, within 30 days postpartum, or breastfeeding
- VA-ECMO applied for reasons other than cardiogenic shock
- Severe blood clotting problems
- Irreversible limb ischemia requiring surgery or intervention at VA-ECMO start (including diagnosed atherosclerosis obliterans)
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Asan Medical Center
Seoul, South Korea, 05505
Actively Recruiting
Research Team
M
Min-Seok Kim, PhD
CONTACT
A
Ah-Ram Kim, MD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here